The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

AIMS: To develop a model for estimating the immediate and long-term healthcare costs associated with seven diabetes-related complications in patients with Type 2 diabetes participating in the UK Prospective Diabetes Study (UKPDS). METHODS: The costs associated with some major complications were esti...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Clarke, P, Gray, A, Legood, R, Briggs, A, Holman, R
Format:	Journal article
Język:	English
Wydane:	2003

Podobne zapisy

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
od: Alva, M, i wsp.
Wydane: (2014)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
od: Clarke, P, i wsp.
Wydane: (2004)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
od: Adler, A, i wsp.
Wydane: (2003)

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
od: Hayes, A, i wsp.
Wydane: (2013)

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82
od: Hayes, A, i wsp.
Wydane: (2013)

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
od: Matthews, DR
Wydane: (1999)

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
od: Matthews, DR
Wydane: (1999)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
od: Davis, T, i wsp.
Wydane: (1999)

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).
od: Clarke, P, i wsp.
Wydane: (2005)

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
od: Adler, A, i wsp.
Wydane: (1999)

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
od: Davis, T, i wsp.
Wydane: (2013)

UKPDS: what was the question? UK Prospective Diabetes Study.
od: Turner, R, i wsp.
Wydane: (1999)

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).
od: Gray, A, i wsp.
Wydane: (2002)

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
od: Turner, R, i wsp.
Wydane: (1998)

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.
od: Gray, A, i wsp.
Wydane: (2000)

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.
od: Gray, A, i wsp.
Wydane: (2000)

Ethnic differences in diabetic nephropathy - The UKPDS
od: Stevens, R, i wsp.
Wydane: (1999)

Estimating the quality of life impact of diabetes related complications: new results from the UKPDS
od: Alva, M, i wsp.
Wydane: (2010)

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).
od: Clarke, P, i wsp.
Wydane: (2002)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
od: Matthews, DR, i wsp.
Wydane: (1998)

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
od: Clarke, P, i wsp.
Wydane: (2001)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
od: Cull, C, i wsp.
Wydane: (2001)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
od: Holman, R
Wydane: (2007)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
od: Holman, R, i wsp.
Wydane: (2001)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
od: Stratton, I, i wsp.
Wydane: (2000)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
od: Wamil, M, i wsp.
Wydane: (2020)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
od: Gray, A, i wsp.
Wydane: (2001)

Life-expectancy projection by modelling and computer simulation (UKPDS 46).
od: Stevens, R, i wsp.
Wydane: (2000)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
od: Kohner, E, i wsp.
Wydane: (2001)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
od: Cull, C, i wsp.
Wydane: (2004)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
od: Turner, R, i wsp.
Wydane: (1999)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
od: Turner, R, i wsp.
Wydane: (1991)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
od: Coleman, R, i wsp.
Wydane: (2005)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
od: Adler, A, i wsp.
Wydane: (2000)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
od: Leal, J, i wsp.
Wydane: (2021)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
od: Kothari, V, i wsp.
Wydane: (2002)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
od: Horton, V, i wsp.
Wydane: (1999)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
od: Stratton, I, i wsp.
Wydane: (2006)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
od: Widjaja, A, i wsp.
Wydane: (1996)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
od: Davis, T, i wsp.
Wydane: (2014)